IMTX
Immatics NV
NASDAQ: IMTX · HEALTHCARE · BIOTECHNOLOGY
$10.99
-1.87% today
Updated 2026-04-30
Market cap
$1.50B
P/E ratio
—
P/S ratio
31.12x
EPS (TTM)
$-1.89
Dividend yield
—
52W range
$4 – $12
Volume
0.5M
Immatics NV (IMTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $20.68M | $70.97M | $-85.61M | $-81.78M | $100.13M | $18.23M | $-158.03M | $-169.66M |
| Capital expenditures | $507000.00 | $2.23M | $7.52M | $5.66M | $6.21M | $30.96M | $16.48M | $6.30M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.48M | $852000.00 | $22.95M | $26.40M | $22.57M | $20.70M | $17.64M | $15.02M |
| Free cash flow | $20.18M | $68.73M | $-93.13M | $-87.44M | $93.92M | $-12.73M | $-174.51M | $-175.95M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |